Invesco Health Care Fund
AIM Investment Funds (Invesco Investment Funds)
+80
New
80
Positions
| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly and Co. | 532457108 | Apr 2025 | 129,157 | $116.1M | 9.53% | EC |
| 2 | Boston Scientific Corp. | 101137107 | Apr 2025 | 1,082,304 | $111.3M | 9.14% | EC |
| 3 | Stryker Corp. | 863667101 | Apr 2025 | 149,541 | $55.9M | 4.59% | EC |
| 4 | Vertex Pharmaceuticals Inc. | 92532F100 | Apr 2025 | 108,176 | $55.1M | 4.53% | EC |
| 5 | UnitedHealth Group Inc. | 91324P102 | Apr 2025 | 133,194 | $54.8M | 4.50% | EC |
| 6 | Cencora, Inc. | 03073E105 | Apr 2025 | 175,335 | $51.3M | 4.21% | EC |
| 7 | AbbVie Inc. | 00287Y109 | Apr 2025 | 256,924 | $50.1M | 4.12% | EC |
| 8 | Intuitive Surgical, Inc. | 46120E602 | Apr 2025 | 77,884 | $40.2M | 3.30% | EC |
| 9 | Abbott Laboratories | 002824100 | Apr 2025 | 286,536 | $37.5M | 3.08% | EC |
| 10 | Invesco Treasury Portfolio | 825252406 | Apr 2025 | 32,128,473 | $32.1M | 2.64% | STIV |
| 11 | Invesco Private Prime Fund | N/A | Apr 2025 | 30,171,594 | $30.2M | 2.48% | STIV |
| 12 | argenx SE | 04016X101 | Apr 2025 | 46,555 | $30.0M | 2.47% | EC |
| 13 | Encompass Health Corp. | 29261A100 | Apr 2025 | 239,475 | $28.0M | 2.30% | EC |
| 14 | AstraZeneca PLC | 046353108 | Apr 2025 | 358,990 | $25.8M | 2.12% | EC |
| 15 | Gilead Sciences, Inc. | 375558103 | Apr 2025 | 223,891 | $23.9M | 1.96% | EC |
| 16 | Welltower Inc. | 95040Q104 | Apr 2025 | 149,244 | $22.8M | 1.87% | EC |
| 17 | Sanofi | 80105N105 | Apr 2025 | 390,717 | $21.5M | 1.76% | EC |
| 18 | Lonza Group AG | N/A | Apr 2025 | 29,526 | $21.2M | 1.74% | EC |
| 19 | McKesson Corp. | 58155Q103 | Apr 2025 | 27,912 | $19.9M | 1.63% | EC |
| 20 | Alnylam Pharmaceuticals, Inc. | 02043Q107 | Apr 2025 | 66,819 | $17.6M | 1.44% | EC |
| 21 | Invesco Government & Agency Portfolio | 825252885 | Apr 2025 | 16,947,707 | $16.9M | 1.39% | STIV |
| 22 | Tenet Healthcare Corp. | 88033G407 | Apr 2025 | 118,107 | $16.9M | 1.39% | EC |
| 23 | Thermo Fisher Scientific Inc. | 883556102 | Apr 2025 | 38,960 | $16.7M | 1.37% | EC |
| 24 | Natera, Inc. | 632307104 | Apr 2025 | 107,406 | $16.2M | 1.33% | EC |
| 25 | Labcorp Holdings Inc. | 504922105 | Apr 2025 | 66,589 | $16.0M | 1.32% | EC |
| 26 | Alcon AG | N/A | Apr 2025 | 153,624 | $14.9M | 1.23% | EC |
| 27 | Insulet Corp. | 45784P101 | Apr 2025 | 57,040 | $14.4M | 1.18% | EC |
| 28 | UCB S.A. | N/A | Apr 2025 | 77,320 | $14.2M | 1.16% | EC |
| 29 | Elevance Health, Inc. | 036752103 | Apr 2025 | 32,528 | $13.7M | 1.12% | EC |
| 30 | Invesco Private Government Fund | N/A | Apr 2025 | 11,586,401 | $11.6M | 0.95% | STIV |
| 31 | Globus Medical, Inc. | 379577208 | Apr 2025 | 157,870 | $11.3M | 0.93% | EC |
| 32 | Ascendis Pharma A/S | 04351P101 | Apr 2025 | 64,321 | $11.0M | 0.90% | EC |
| 33 | ResMed Inc. | 761152107 | Apr 2025 | 45,575 | $10.8M | 0.89% | EC |
| 34 | HealthEquity, Inc. | 42226A107 | Apr 2025 | 112,852 | $9.7M | 0.79% | EC |
| 35 | Exelixis, Inc. | 30161Q104 | Apr 2025 | 245,339 | $9.6M | 0.79% | EC |
| 36 | Repligen Corp. | 759916109 | Apr 2025 | 62,581 | $8.6M | 0.71% | EC |
| 37 | ADMA Biologics, Inc. | 000899104 | Apr 2025 | 361,495 | $8.6M | 0.71% | EC |
| 38 | Royalty Pharma PLC | G7709Q104 | Apr 2025 | 257,551 | $8.5M | 0.69% | EC |
| 39 | HCA Healthcare, Inc. | 40412C101 | Apr 2025 | 23,995 | $8.3M | 0.68% | EC |
| 40 | Insmed Inc. | 457669307 | Apr 2025 | 114,163 | $8.2M | 0.67% | EC |
| 41 | Molina Healthcare, Inc. | 60855R100 | Apr 2025 | 22,956 | $7.5M | 0.62% | EC |
| 42 | Waystar Holding Corp. | 946784105 | Apr 2025 | 200,366 | $7.4M | 0.61% | EC |
| 43 | Zoetis Inc. | 98978V103 | Apr 2025 | 47,375 | $7.4M | 0.61% | EC |
| 44 | BridgeBio Pharma, Inc. | 10806X102 | Apr 2025 | 187,384 | $7.2M | 0.59% | EC |
| 45 | Guardant Health, Inc. | 40131M109 | Apr 2025 | 143,042 | $6.8M | 0.55% | EC |
| 46 | Blueprint Medicines Corp. | 09627Y109 | Apr 2025 | 74,381 | $6.7M | 0.55% | EC |
| 47 | Integer Holdings Corp. | 45826H109 | Apr 2025 | 50,805 | $6.4M | 0.53% | EC |
| 48 | Axsome Therapeutics, Inc. | 05464T104 | Apr 2025 | 55,869 | $6.3M | 0.52% | EC |
| 49 | Penumbra, Inc. | 70975L107 | Apr 2025 | 20,943 | $6.1M | 0.50% | EC |
| 50 | Halozyme Therapeutics, Inc. | 40637H109 | Apr 2025 | 97,938 | $6.0M | 0.49% | EC |
| 51 | BrightSpring Health Services, Inc. | 10950A106 | Apr 2025 | 329,583 | $5.8M | 0.47% | EC |
| 52 | Merit Medical Systems, Inc. | 589889104 | Apr 2025 | 56,488 | $5.3M | 0.44% | EC |
| 53 | Tarsus Pharmaceuticals, Inc. | 87650L103 | Apr 2025 | 91,276 | $4.7M | 0.39% | EC |
| 54 | Protagonist Therapeutics, Inc. | 74366E102 | Apr 2025 | 98,484 | $4.5M | 0.37% | EC |
| 55 | Glaukos Corp. | 377322102 | Apr 2025 | 45,825 | $4.3M | 0.35% | EC |
| 56 | Lantheus Holdings, Inc. | 516544103 | Apr 2025 | 40,193 | $4.2M | 0.34% | EC |
| 57 | IDEXX Laboratories, Inc. | 45168D104 | Apr 2025 | 9,482 | $4.1M | 0.34% | EC |
| 58 | Twist Bioscience Corp. | 90184D100 | Apr 2025 | 104,232 | $4.0M | 0.33% | EC |
| 59 | LeMaitre Vascular, Inc. | 525558201 | Apr 2025 | 41,722 | $3.8M | 0.31% | EC |
| 60 | Alignment Healthcare, Inc. | 01625V104 | Apr 2025 | 210,375 | $3.7M | 0.31% | EC |
| 61 | Kestra Medical Technologies Ltd. | G52441105 | Apr 2025 | 152,593 | $3.7M | 0.30% | EC |
| 62 | Mettler-Toledo International Inc. | 592688105 | Apr 2025 | 3,273 | $3.5M | 0.29% | EC |
| 63 | Krystal Biotech, Inc. | 501147102 | Apr 2025 | 20,496 | $3.5M | 0.29% | EC |
| 64 | Vericel Corp. | 92346J108 | Apr 2025 | 89,775 | $3.4M | 0.28% | EC |
| 65 | Ligand Pharmaceuticals Inc. | 53220K504 | Apr 2025 | 30,494 | $3.4M | 0.28% | EC |
| 66 | Sandoz Group AG | H7140B103 | Apr 2025 | 75,786 | $3.3M | 0.27% | EC |
| 67 | Concentra Group Holdings Parent, Inc. | 20603L102 | Apr 2025 | 146,155 | $3.2M | 0.26% | EC |
| 68 | SpringWorks Therapeutics, Inc. | 85205L107 | Apr 2025 | 67,510 | $3.1M | 0.26% | EC |
| 69 | RadNet, Inc. | 750491102 | Apr 2025 | 59,431 | $3.1M | 0.26% | EC |
| 70 | Doximity, Inc. | 26622P107 | Apr 2025 | 53,337 | $3.0M | 0.25% | EC |
| 71 | GeneDx Holdings Corp. | 81663L200 | Apr 2025 | 44,932 | $3.0M | 0.25% | EC |
| 72 | Cytokinetics, Inc. | 23282W605 | Apr 2025 | 67,433 | $2.9M | 0.24% | EC |
| 73 | Merus N.V. | N5749R100 | Apr 2025 | 61,150 | $2.8M | 0.23% | EC |
| 74 | BioLife Solutions, Inc. | 09062W204 | Apr 2025 | 113,958 | $2.7M | 0.23% | EC |
| 75 | Bio-Techne Corp. | 09073M104 | Apr 2025 | 47,511 | $2.4M | 0.20% | EC |
| 76 | CareDx, Inc. | 14167L103 | Apr 2025 | 124,378 | $2.1M | 0.17% | EC |
| 77 | Procept Biorobotics Corp. | 74276L105 | Apr 2025 | 34,218 | $1.8M | 0.15% | EC |
| 78 | Soleno Therapeutics, Inc. | 834203309 | Apr 2025 | 22,963 | $1.7M | 0.14% | EC |
| 79 | Janux Therapeutics, Inc. | 47103J105 | Apr 2025 | 35,961 | $1.2M | 0.10% | EC |
| 80 | Phathom Pharmaceuticals, Inc. | 71722W107 | Apr 2025 | 104,826 | $450K | 0.04% | EC |